Bold claim: Minimally invasive laparoscopy for Kasai surgery yields better short-term jaundice clearance and less blood loss in infants with biliary atresia, without sacrificing long-term survival. But here’s where it gets controversial: does this one-size-fits-all approach truly outperform traditional open surgery in every setting?
A new study reports that using laparoscopy to perform the Kasai portoenterostomy—an operation intended to restore bile flow from the liver to the intestines—results in significantly less blood loss and higher rates of jaundice clearance compared with the conventional open method in babies with biliary atresia (BA). Jaundice, the yellowing of the skin and eyes caused by bile buildup in the bloodstream, is a common sign of BA and a key metric of early surgical success.
However, when looking at longer-term outcomes such as survival without liver transplantation, the study found no meaningful difference between the two approaches. Notably, the laparoscopic procedure took longer to perform, on average.
An additional finding concerns postoperative steroid use. Infants who did not achieve jaundice clearance after surgery tended to receive higher doses of prednisolone, a drug used to suppress inflammation and modulate the immune response. Yet this intensified steroid strategy did not translate into better long-term results and was associated with an increased likelihood of needing a liver transplant.
Taken together, the researchers suggest that laparoscopy could be considered the first-line option for Kasai surgery in BA, and they caution against escalating steroid doses with the aim of extending native liver survival. These implications come from a multicenter study that analyzed outcomes in 356 infants with BA who underwent Kasai procedures between 2000 and 2022 at centers across Asia.
What the study adds, and what it doesn’t, is important to appreciate. While the laparoscopy group showed a higher rate of short-term jaundice clearance (about 81% vs. 64%), long-term results—death or transplant-free survival in five years—were similar between groups. In addition, laparoscopy tended to reduce blood loss by about two-thirds, albeit with a longer operative time. Surgical complication rates were similar between the two approaches.
Methodologically, the researchers used propensity score matching to balance preoperative differences and compared outcomes over a median follow-up of 13 years. Their conclusions emphasize that, given comparable long-term survival and transplant rates, laparoscopic Kasai surgery can be adopted as a standard treatment option for BA. They also highlight a key caveat: increasing prednisolone doses beyond a certain threshold did not improve native liver survival and might raise transplant risk.
For readers seeking context, BA is a congenital condition where bile ducts are absent or obstructed, causing bile to back up in the liver and potentially leading to liver damage. The Kasai procedure aims to create a new route for bile to flow from the liver to the intestine, but BA can progress to more severe liver disease over time, sometimes necessitating a liver transplant.
Bottom line: The shift toward minimally invasive Kasai surgery shows clear advantages in immediate blood loss and jaundice resolution, with similar five-year survival compared to the open method. But the strategy of higher steroid dosing to prolong the native liver’s life does not seem beneficial and may carry risks. As always, treatment decisions should be individualized, and ongoing research will refine best practices.
Would you consider laparoscopy the preferred approach for Kasai surgery in BA based on these findings, or would you wait for more long-term data and protocol standardization regarding postoperative steroid use?
